Related Experiment Video
Updated: Feb 4, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen
Maisem Laabei1, Guanghui Liu1, David Ermert1
1Division of Medical Protein Chemistry, Lund University, 21428 Malmö, Sweden.
Abstract:
The respiratory pathogen Moraxella catarrhalis is a human-specific commensal that frequently causes acute otitis media in children and stimulates acute exacerbations in chronic obstructive pulmonary disease patients. The exact molecular mechanisms defining host-pathogen interactions promoting pathogenesis are not clearly understood. Limited knowledge hampers vaccine and immunotherapeutic development required to treat this emerging pathogen. In this study, we reveal in detail a novel antibacterial role displayed by short leucine-rich proteoglycans (SLRPs) in concert with complement. We show that fibromodulin (FMOD), osteoadherin (OSAD), and biglycan (BGN) but not decorin (DCN) enhance serum killing of M. catarrhalis. Our results suggest that M. catarrhalis binding to SLRPs is a conserved feature, as the overwhelming majority of clinical and laboratory strains bound all four SLRPs. Furthermore, we resolve the binding mechanism responsible for this interaction and highlight the role of the ubiquitous surface protein (Usp) A2/A2H in mediating binding to host SLRPs. A conserved immune evasive strategy used by M. catarrhalis and other pathogens is the surface acquisition of host complement inhibitors such as C4b-binding protein (C4BP). We observed that FMOD, OSAD, and BGN competitively inhibit binding of C4BP to the surface of M. catarrhalis, resulting in increased C3b/iC3b deposition, membrane attack complex (MAC) formation, and subsequently decreased bacterial survival. Furthermore, both OSAD and BGN promote enhanced neutrophil killing in vitro, both in a complement-dependent and independent fashion. In summary, our results illustrate that SLRPs, FMOD, OSAD, and BGN portray complement-modulating activity enhancing M. catarrhalis killing, defining a new antibacterial role supplied by SLRPs.
Insights
Short leucine-rich proteoglycans (SLRPs) enhance the immune system's ability to kill the pathogen Moraxella catarrhalis. These SLRPs, including fibromodulin, osteoadherin, and biglycan, inhibit immune evasion and promote bacterial clearance.
Area of Science:
- Microbiology
- Immunology
- Biochemistry
Background:
- Moraxella catarrhalis is a significant respiratory pathogen causing otitis media and COPD exacerbations.
- The molecular mechanisms of M. catarrhalis pathogenesis and host interactions are not well understood.
- Developing effective vaccines and immunotherapies against M. catarrhalis is hindered by limited knowledge.
Purpose of the Study:
- To investigate the novel antibacterial role of short leucine-rich proteoglycans (SLRPs) in host defense against M. catarrhalis.
- To elucidate the mechanisms by which SLRPs modulate the host immune response to M. catarrhalis.
- To identify potential therapeutic targets for treating M. catarrhalis infections.
Main Methods:
- Assessed the ability of fibromodulin (FMOD), osteoadherin (OSAD), biglycan (BGN), and decorin (DCN) to enhance serum killing of M. catarrhalis.
- Investigated M. catarrhalis binding to SLRPs across various clinical and laboratory strains.
- Utilized surface protein A2/A2H (UspA2/A2H) to resolve SLRP binding mechanisms.
- Examined the competitive inhibition of C4b-binding protein (C4BP) by SLRPs.
- Measured C3b/iC3b deposition and membrane attack complex (MAC) formation.
- Evaluated neutrophil killing of M. catarrhalis in vitro.
Main Results:
- FMOD, OSAD, and BGN significantly enhanced serum-mediated killing of M. catarrhalis.
- M. catarrhalis demonstrated conserved binding to all tested SLRPs, mediated by UspA2/A2H.
- SLRPs competitively inhibited C4BP binding, leading to increased complement deposition (C3b/iC3b) and MAC formation.
- OSAD and BGN promoted enhanced neutrophil killing, both complement-dependent and independent.
- Decorin (DCN) did not enhance M. catarrhalis killing.
Conclusions:
- SLRPs, specifically FMOD, OSAD, and BGN, possess a novel antibacterial function against M. catarrhalis.
- These SLRPs enhance bacterial killing by modulating complement activation and inhibiting immune evasion.
- SLRPs represent a promising target for developing new therapeutic strategies against M. catarrhalis infections.
Related Concept Videos
Proteoglycans
Matrix Proteoglycans and Glycoproteins
Complement System
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Increasing Function

